Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment

被引:50
作者
Xu, Yuanxin [1 ,2 ]
Feng, Kuanhan [1 ,2 ]
Zhao, Huacong [1 ,2 ]
Di, Liuqing [1 ,2 ]
Wang, Lei [3 ]
Wang, Ruoning [1 ,2 ]
机构
[1] Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China
[2] Jiangsu Prov TCM Engn Technol Res Ctr High Effici, Nanjing 210023, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor-derived extracellular vesicles; Drug delivery systems; Cancer therapy; Exosomes; Clinical research progress; THERAPY RECENT ADVANCES; SURFACE FUNCTIONALIZATION; ENGINEERING EXOSOMES; DELIVERY-SYSTEMS; HUMAN PLASMA; BIOLOGY; BIOGENESIS; CELLS; MICROENVIRONMENT; ANGIOGENESIS;
D O I
10.7150/thno.67775
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Extracellular vesicles (EVs) are kinds of two-layer vesicles secreted by cells. They play significant roles in mediating component exchange between cells, signal transduction, and pathological development. Among them, the tumor-derived EVs (TDEVs) are found related to the tumor microenvironment and cancer development. TDEVs can be designed as a natural drug carrier with high tumor targeting and permeability. In recent years, drug delivery systems (DDS) based on TDEVs for cancer treatments have received considerable attention. In this review, the biological characteristics of TDEVs are introduced, especially the effect on the tumor. Furthermore, the various approaches to constructing DDS based on TDEVs are summarized. Then we listed examples of TDEVs successfully constructing treatment systems. The use of chemical drugs, biological drugs, and engineered drugs as encapsulated drugs are respectively introduced, particularly the application progress of active ingredients in traditional Chinese medicine. Finally, this article introduces the latest clinical research progress, especially the marketed preparations and challenges of clinical application of TDEVs.
引用
收藏
页码:1683 / 1714
页数:32
相关论文
共 200 条
[31]   Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines [J].
Fernandez-Delgado, Irene ;
Calzada-Fraile, Diego ;
Sanchez-Madrid, Francisco .
CANCERS, 2020, 12 (12) :1-23
[32]   Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography [J].
Foers, Andrew D. ;
Chatfield, Simon ;
Dagley, Laura F. ;
Scicluna, Benjamin J. ;
Webb, Andrew I. ;
Cheng, Lesley ;
Hill, Andrew F. ;
Wicks, Ian P. ;
Pang, Ken C. .
JOURNAL OF EXTRACELLULAR VESICLES, 2018, 7 (01)
[33]   Extracellular Vesicle Dissemination of Epidermal Growth Factor Receptor and Ligands and Its Role in Cancer Progression [J].
Frawley, Thomas ;
Piskareva, Olga .
CANCERS, 2020, 12 (11) :1-13
[34]   Different isolation approaches lead to diverse glycosylated extracellular vesicle populations [J].
Freitas, Daniela ;
Balmana, Meritxell ;
Pocas, Juliana ;
Campos, Diana ;
Osorio, Hugo ;
Konstantinidi, Andriana ;
Vakhrushev, Sergey Y. ;
Magalhaes, Ana ;
Reis, Celso A. .
JOURNAL OF EXTRACELLULAR VESICLES, 2019, 8 (01)
[35]   Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins [J].
Fuhrmann, Gregor ;
Serio, Andrea ;
Mazo, Manuel ;
Nair, Rekha ;
Stevens, Molly M. .
JOURNAL OF CONTROLLED RELEASE, 2015, 205 :35-44
[36]   Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes [J].
Garcia-Manrique, Pablo ;
Matos, Maria ;
Gutierrez, Gemma ;
Pazos, Carmen ;
Carmen Blanco-Lopez, Maria .
JOURNAL OF EXTRACELLULAR VESICLES, 2018, 7 (01)
[37]   Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice [J].
Garofalo, M. ;
Villa, A. ;
Rizzi, N. ;
Kuryk, L. ;
Rinner, B. ;
Cerullo, V ;
Yliperttula, M. ;
Mazzaferro, V ;
Ciana, P. .
JOURNAL OF CONTROLLED RELEASE, 2019, 294 :165-175
[38]   Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment [J].
Garofalo, M. ;
Saari, H. ;
Somersalo, P. ;
Crescenti, D. ;
Kuryk, L. ;
Aksela, L. ;
Capasso, C. ;
Madetoja, M. ;
Koskinen, K. ;
Oksanen, T. ;
Makitie, A. ;
Jalasvuori, M. ;
Cerullo, V. ;
Ciana, P. ;
Yliperttula, M. .
JOURNAL OF CONTROLLED RELEASE, 2018, 283 :223-234
[39]  
Garofalo Mariangela, 2021, Nanotheranostics, V5, P1, DOI 10.7150/ntno.47226
[40]   Simple and Fast SEC-Based Protocol to Isolate Human Plasma-Derived Extracellular Vesicles for Transcriptional Research [J].
Gaspar, Laetitia S. ;
Santana, Magda M. ;
Henriques, Carina ;
Pinto, Maria M. ;
Ribeiro-Rodrigues, Teresa M. ;
Girao, Henrique ;
Nobre, Rui Jorge ;
de Almeida, Luis Pereira .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 :723-737